Predict your next investment

Lantos Technologies company logo
HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
lantostechnologies.com

See what CB Insights has to offer

Executives

12

Board of Directors

3

Lantos Technologies Board of Directors

3 Board of directors

Lantos Technologies has 3 board of directors, including Darshana Zaveri.

Name

Firm

Work History

Other Seats

Darshana Zaveri

Darshana Zaveri is a Managing Partner of Catalyst Health Ventures. Darshana is actively involved in all aspects of Fund Management including Investments and Capital Raising. She led Catalyst’s investments in Augmenix (acquired by Boston Scientific, NYSE: BSX), Lantos Technologies, nVision Medical (acquired by Boston Scientific, NYSE: BSX), Maxwell Health (Acquired by Sun Life Financial, NYSE: SLF), Aria CV, and Hepregen. She currently represents Catalyst on the Boards of Lantos (past Chair), Aria CV (Chair), while previously serving on the boards of nVision, Augmenix, and Maxwell Health. She was also actively involved with portfolio company Allegro Diagnostics, Inc. (acquired by Veracyte, NASDAQ: VCT) Darshana brings to Catalyst over a decade of experience in the health care and Life Science Industries. Prior to Catalyst, she was an Investigator at Vertex Pharmaceuticals and an integral part of the drug development programs in oncology, metabolic disease, and immunology. Previously she worked at Genome Therapeutics, a Massachusetts-based biotechnology company, at the Dana Farber Cancer Institute, and completed an internship at the United Nations. She has authored several publications and scientific journal articles and currently serves as a Catalyst of the Deshpande Center for Technological Innovation at MIT. Darshana received an MPA from Harvard University, a MS degree in Cell and Molecular Biology from Boston University, and a BS in Biochemistry from Bombay University in Bombay, India.

Lantos Technologies, and Lantos Technologies

Gaye Bok

Venture investor experienced in sourcing, evaluating, investing and managing investments in digital healthcare, nutrition, life sciences and energy industries. Versatile business development executive with demonstrated skill in developing strategic partnerships, managing new product development programs and portfolios as well as commercializing new products.

Lantos Technologies

Tasneem Dohadwala

As Founding Partner of Excelestar Ventures, notable investments of hers are Augmenix (acq. by Boston Scientific), nVision (acq. by Boston Scientific), Lantos Technologies, Conformal Medical, Brixton Biosciences and Altiostar Networks. Furthermore, she sits on the investment committee of Catalyst Healthcare Ventures III. She is also a Managing Partner of Golden Seeds. She remains heavily active in her investments and is actively deploying capital in Series A round and beyond. She also contributed an essay, “Women and the Workplace,” to the book, Passion & Purpose: Stories from the Best and Brightest Young Business Leaders. Tasneem has always been excited to further women leadership and women in business. Throughout her career, Tasneem has thought about the female experience; starting from being a young, active member of the Women of Lehman Brothers, then leading as President of Wellesley College Alumnae Boston (Wellesley College’s largest alumnae organization), and now finally being a Managing Director of Golden Seeds. She is passionately and deliberately mentoring and searching for female-led companies. She believes that investing in women is the best way to bring more women into leadership roles

Lantos Technologies

Name

Darshana Zaveri

Gaye Bok

Tasneem Dohadwala

Firm

Work History

Darshana Zaveri is a Managing Partner of Catalyst Health Ventures. Darshana is actively involved in all aspects of Fund Management including Investments and Capital Raising. She led Catalyst’s investments in Augmenix (acquired by Boston Scientific, NYSE: BSX), Lantos Technologies, nVision Medical (acquired by Boston Scientific, NYSE: BSX), Maxwell Health (Acquired by Sun Life Financial, NYSE: SLF), Aria CV, and Hepregen. She currently represents Catalyst on the Boards of Lantos (past Chair), Aria CV (Chair), while previously serving on the boards of nVision, Augmenix, and Maxwell Health. She was also actively involved with portfolio company Allegro Diagnostics, Inc. (acquired by Veracyte, NASDAQ: VCT) Darshana brings to Catalyst over a decade of experience in the health care and Life Science Industries. Prior to Catalyst, she was an Investigator at Vertex Pharmaceuticals and an integral part of the drug development programs in oncology, metabolic disease, and immunology. Previously she worked at Genome Therapeutics, a Massachusetts-based biotechnology company, at the Dana Farber Cancer Institute, and completed an internship at the United Nations. She has authored several publications and scientific journal articles and currently serves as a Catalyst of the Deshpande Center for Technological Innovation at MIT. Darshana received an MPA from Harvard University, a MS degree in Cell and Molecular Biology from Boston University, and a BS in Biochemistry from Bombay University in Bombay, India.

Venture investor experienced in sourcing, evaluating, investing and managing investments in digital healthcare, nutrition, life sciences and energy industries. Versatile business development executive with demonstrated skill in developing strategic partnerships, managing new product development programs and portfolios as well as commercializing new products.

As Founding Partner of Excelestar Ventures, notable investments of hers are Augmenix (acq. by Boston Scientific), nVision (acq. by Boston Scientific), Lantos Technologies, Conformal Medical, Brixton Biosciences and Altiostar Networks. Furthermore, she sits on the investment committee of Catalyst Healthcare Ventures III. She is also a Managing Partner of Golden Seeds. She remains heavily active in her investments and is actively deploying capital in Series A round and beyond. She also contributed an essay, “Women and the Workplace,” to the book, Passion & Purpose: Stories from the Best and Brightest Young Business Leaders. Tasneem has always been excited to further women leadership and women in business. Throughout her career, Tasneem has thought about the female experience; starting from being a young, active member of the Women of Lehman Brothers, then leading as President of Wellesley College Alumnae Boston (Wellesley College’s largest alumnae organization), and now finally being a Managing Director of Golden Seeds. She is passionately and deliberately mentoring and searching for female-led companies. She believes that investing in women is the best way to bring more women into leadership roles

Other Seats

Lantos Technologies, and Lantos Technologies

Lantos Technologies

Lantos Technologies

Lantos Technologies Management Team

12 Team Members

Lantos Technologies has 12 executives. Lantos Technologies's founder is Shahid Azim. Lantos Technologies's current Chief Executive Officer is Paul Harkness.

Name

Work History

Title

Status

Shahid Azim

Founder

Current

Brian Fligor

Founder

Current

Paul Harkness

Chief Executive Officer

Current

Joe St Cyr

Chief Technology Officer

Current

John L Bojanowski

Chief Executive Officer

Former

Name

Shahid Azim

Brian Fligor

Paul Harkness

Joe St Cyr

John L Bojanowski

Work History

Title

Founder

Founder

Chief Executive Officer

Chief Technology Officer

Chief Executive Officer

Status

Current

Current

Current

Current

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.